• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Psoriatic disease treatment nowadays: unmet needs among the "jungle of biologic drugs and small molecules".

作者信息

Megna Matteo, Balato Anna, Napolitano Maddalena, Gallo Lucia, Caso Francesco, Costa Luisa, Balato Nicola, Scarpa Raffaele

机构信息

Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.

Department of Advanced Biomedical Sciences, Dermatology Unit, University of Naples Federico II, Naples, Italy.

出版信息

Clin Rheumatol. 2018 Jul;37(7):1739-1741. doi: 10.1007/s10067-018-4090-6. Epub 2018 Apr 11.

DOI:10.1007/s10067-018-4090-6
PMID:29644570
Abstract
摘要

相似文献

1
Psoriatic disease treatment nowadays: unmet needs among the "jungle of biologic drugs and small molecules".当今银屑病疾病的治疗：生物药物和小分子药物“丛林”中的未满足需求
Clin Rheumatol. 2018 Jul;37(7):1739-1741. doi: 10.1007/s10067-018-4090-6. Epub 2018 Apr 11.
2
Tailored treatment options for patients with psoriatic arthritis and psoriasis: review of established and new biologic and small molecule therapies.银屑病关节炎和银屑病患者的定制治疗方案：已确立及新型生物制剂和小分子疗法综述
Rheumatol Int. 2016 May;36(5):603-12. doi: 10.1007/s00296-016-3436-0. Epub 2016 Feb 18.
3
Current pharmacological treatment guidelines for psoriasis and psoriatic arthritis.目前针对银屑病和银屑病关节炎的药理学治疗指南。
Expert Rev Clin Pharmacol. 2018 Dec;11(12):1209-1218. doi: 10.1080/17512433.2018.1548277. Epub 2018 Dec 4.
4
Induction of remission in biologic-naive, severe psoriasis and PsA with dual anti-cytokine combination.使用双抗细胞因子联合疗法诱导初治的重度银屑病和银屑病关节炎缓解。
Rheumatology (Oxford). 2021 Jul 1;60(7):e225-e226. doi: 10.1093/rheumatology/keaa880.
5
Hyperlipidaemia in psoriatic disease: higher prevalence in psoriatic arthritis and inverse association with systemic therapy.银屑病性疾病中的高脂血症：在银屑病关节炎中患病率更高且与全身治疗呈负相关。
Rheumatology (Oxford). 2021 Aug 2;60(8):3949-3951. doi: 10.1093/rheumatology/keab365.
6
Intercepting psoriatic arthritis in patients with psoriasis: buy one get one free?对银屑病患者进行银屑病关节炎的早期干预：买一送一？
Ann Rheum Dis. 2022 Jan;81(1):7-10. doi: 10.1136/annrheumdis-2021-221255. Epub 2021 Nov 22.
7
Treatment of recalcitrant psoriasis and psoriatic arthritis with a combination of a biologic plus an oral JAK or TYK2 inhibitor: a case series.使用生物制剂加口服JAK或TYK2抑制剂联合治疗顽固性银屑病和银屑病关节炎：病例系列
Ann Rheum Dis. 2024 Sep 30;83(10):1392-1393. doi: 10.1136/ard-2024-225800.
8
First-time prescriptions of biological disease-modifying antirheumatic drugs in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis 2002-2011: data from the NOR-DMARD register.2002年至2011年类风湿关节炎、银屑病关节炎和轴性脊柱关节炎中生物性改善病情抗风湿药物的首次处方：来自北欧改善病情抗风湿药物登记处的数据
Ann Rheum Dis. 2014 Oct;73(10):1905-6. doi: 10.1136/annrheumdis-2014-205490. Epub 2014 Jul 2.
9
Biologics in psoriatic patients with malignancies: Where are we now? An Italian multicentric study.患有恶性肿瘤的银屑病患者使用生物制剂的现状：我们目前处于什么情况？一项意大利多中心研究。
J Eur Acad Dermatol Venereol. 2024 Apr;38(4):e331-e334. doi: 10.1111/jdv.19603. Epub 2023 Nov 10.
10
Physician perspectives in the management of psoriasis and psoriatic arthritis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis survey.银屑病和银屑病关节炎管理中的医生观点：基于人群的银屑病和银屑病关节炎多国评估调查结果
J Eur Acad Dermatol Venereol. 2015 Oct;29(10):2002-10. doi: 10.1111/jdv.13150. Epub 2015 Apr 16.

引用本文的文献

1
First-in-Human Single and Multiple Ascending Dose Studies of Balinatunfib, a Small Molecule Inhibitor of TNFR1 Signaling in Healthy Participants.巴利那图单抗（一种TNFR1信号小分子抑制剂）在健康受试者中的首次人体单剂量和多剂量递增研究。
Clin Pharmacol Ther. 2025 Jul;118(1):164-176. doi: 10.1002/cpt.3655. Epub 2025 Mar 30.
2
Effectiveness of secukinumab in patients with psoriasis and psoriatic arthritis in a Saudi real-world setting.沙特真实世界环境中司库奇尤单抗治疗银屑病和银屑病关节炎患者的疗效。
Adv Rheumatol. 2024 Apr 29;64(1):34. doi: 10.1186/s42358-024-00371-1.
3
Long-term efficacy and safety of guselkumab in Chinese patients with moderate-to-severe plaque psoriasis.

本文引用的文献

1
Guselkumab for the treatment of psoriasis.古塞库单抗治疗银屑病。
Expert Opin Biol Ther. 2018 Apr;18(4):459-468. doi: 10.1080/14712598.2018.1445223. Epub 2018 Mar 3.
2
Psoriatic arthritis: tissue-directed inflammation?银屑病关节炎：组织靶向性炎症？
Clin Rheumatol. 2018 Apr;37(4):859-868. doi: 10.1007/s10067-018-4012-7. Epub 2018 Feb 23.
3
Spondyloarthritis: Which composite measures to use in psoriatic arthritis?脊柱关节炎：银屑病关节炎应采用哪些综合指标？
古塞库单抗治疗中国中度至重度斑块状银屑病患者的长期疗效和安全性。
Front Med (Lausanne). 2023 Dec 14;10:1285972. doi: 10.3389/fmed.2023.1285972. eCollection 2023.
4
Injections Site Reactions and Biologics for Psoriasis: A Questionnaire Based Real Life Study.银屑病的注射部位反应与生物制剂：一项基于问卷调查的真实生活研究。
Clin Cosmet Investig Dermatol. 2023 Mar 2;16:553-564. doi: 10.2147/CCID.S400679. eCollection 2023.
5
Eczematous eruption after brodalumab successfully treated with guselkumab and dupilumab.布罗达单抗治疗成功后出现湿疹样皮疹，使用古塞库单抗和度普利尤单抗治疗。
Dermatol Ther. 2022 Nov;35(11):e15839. doi: 10.1111/dth.15839. Epub 2022 Sep 23.
6
Bimekizumab for the Treatment of Psoriasis: A Review of the Current Knowledge.用于治疗银屑病的比美吉珠单抗：当前知识综述
Psoriasis (Auckl). 2022 Jun 8;12:127-137. doi: 10.2147/PTT.S367744. eCollection 2022.
7
Hepatitis Virus Reactivation in Patients with Psoriasis Treated with Secukinumab in a Real-World Setting of Hepatitis B or Hepatitis C Infection.在乙型肝炎或丙型肝炎感染的真实世界环境中，用司库奇尤单抗治疗银屑病的患者中肝炎病毒再激活。
Clin Drug Investig. 2022 Jun;42(6):525-531. doi: 10.1007/s40261-022-01163-5. Epub 2022 May 28.
8
Risankizumab treatment in psoriasis patients who failed anti-IL17: A 52-week real-life study.利纳西珠单抗治疗抗 IL17 治疗失败的银屑病患者：一项 52 周的真实世界研究。
Dermatol Ther. 2022 Jul;35(7):e15524. doi: 10.1111/dth.15524. Epub 2022 Apr 26.
9
Brodalumab Is Associated with High Rates of Complete Clearance and Quality of Life Improvement: A Subgroup Analysis of Patients with Psoriasis and Concomitant Psoriatic Arthritis.布罗达卢单抗与高完全清除率和生活质量改善相关：伴有银屑病和并发银屑病关节炎患者的亚组分析。
Dermatology. 2022;238(4):620-629. doi: 10.1159/000520290. Epub 2021 Nov 25.
10
Real world practice indirect comparison between guselkumab and risankizumab: Results from an Italian retrospective study.意大利一项回顾性研究显示，古塞库单抗与里沙鲁单抗在真实世界实践中的间接比较结果。
Dermatol Ther. 2022 Jan;35(1):e15214. doi: 10.1111/dth.15214. Epub 2021 Nov 30.
Nat Rev Rheumatol. 2018 Mar;14(3):125-126. doi: 10.1038/nrrheum.2018.15. Epub 2018 Feb 8.
4
Metabolic syndrome in psoriatic arthritis: the interplay with cutaneous involvement. Evidences from literature and a recent cross-sectional study.银屑病关节炎中的代谢综合征：与皮肤受累的相互作用。文献和最近一项横断面研究的证据。
Clin Rheumatol. 2018 Mar;37(3):579-586. doi: 10.1007/s10067-017-3975-0. Epub 2018 Jan 8.
5
Switching Between Biological Treatments in Psoriatic Arthritis: A Review of the Evidence.在银屑病关节炎中转换生物治疗：证据回顾。
Drugs R D. 2017 Dec;17(4):509-522. doi: 10.1007/s40268-017-0215-7.
6
Tofacitinib for Psoriatic Arthritis in Patients with an Inadequate Response to TNF Inhibitors.托法替布治疗对 TNF 抑制剂应答不足的银屑病关节炎患者。
N Engl J Med. 2017 Oct 19;377(16):1525-1536. doi: 10.1056/NEJMoa1615977.
7
Small molecule therapy for managing moderate to severe psoriatic arthritis.用于治疗中度至重度银屑病关节炎的小分子疗法。
Expert Opin Pharmacother. 2017 Oct;18(15):1557-1567. doi: 10.1080/14656566.2017.1378343. Epub 2017 Sep 18.
8
Psoriatic Disease 10 Years Later.十年后的银屑病疾病
J Rheumatol. 2017 Sep;44(9):1298-1301. doi: 10.3899/jrheum.161402.
9
Evidence-based algorithm for diagnosis and assessment in psoriatic arthritis: results by Italian DElphi in psoriatic Arthritis (IDEA).银屑病关节炎诊断与评估的循证算法：意大利银屑病关节炎德尔菲研究（IDEA）结果
Reumatismo. 2016 Dec 16;68(3):126-136. doi: 10.4081/reumatismo.2016.913.
10
Psoriatic arthritis and psoriasis: differential diagnosis.银屑病关节炎与银屑病：鉴别诊断
Clin Rheumatol. 2016 Aug;35(8):1893-1901. doi: 10.1007/s10067-016-3295-9. Epub 2016 May 7.